Table 4.
Effect | “Limited” overall study quality (n = 22) | Univariate analysis | ||
---|---|---|---|---|
Odds ratio | 95% CI | p-value | ||
Age > 65 years | 12 (54.5%) | 2.23 | 0.64–7.74 | 0.207 |
Male | 16 (72.7%) | 3.26 | 0.09–11.80 | 0.072 |
BMI > 30 (kg/m2) | 14 (63.6%) | 4.08 | 1.12–14.86 | 0.033* |
Presence of ICD | 17 (77.3%) | 7.93 | 1.99–31.59 | 0.003* |
Atrial fibrillation | 8 (36.3%) | 1.71 | 0.45–6.51 | 0.428 |
LVEF ≤ 35% | 10 (45.5%) | 7.50 | 1.39–40.43 | 0.019* |
NYHA class > I | 13 (59.1%) | 3.37 | 0.94–12.12 | 0.063 |
Diuretics | 13 (59.1%) | 4.33 | 1.16–16.25 | 0.03* |
OSA | 5 (22.7%) | 0.88 | 0.21–3.65 | 0.863 |
COPD was not included in the regression model because only one patient had COPD
(*) Statistically significant